Comparison of the efficacy of adalimumab and ustekinumab for prevention of intestinal fibrosis in bio-naive Crohn's Disease patients

被引：0
|
作者：
Biscanin, A. [1 ,2 ]
Tomasic, V. [1 ]
Babic, F. [1 ]
Cacic, P. [1 ]
Kordej, D. Ogresta [1 ]
Hrabar, D. [1 ,2 ]
Kralj, D. [1 ]
Dorosulic, Z. [1 ]
机构：
[1] Sisters Char Univ Hosp, Dept Gastroenterol, Zagreb, Croatia
[2] Univ Zagreb, Sch Med, Zagreb, Croatia
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P565
引用
收藏
页码：695 / 695
页数：1
相关论文
共 50 条
  • [21] Real-World Clinical Effectiveness and Safety of Vedolizumab and Ustekinumab in Bio-Naive Patients With Early Crohn's Disease: Results From the EVOLVE Expansion Study
    Christensen, Britt
    Scharl, Michael
    Bressler, Brian
    Khan, Zaeem
    Halchenko, Yuliya
    Kamble, Pravin
    Adsul, Shashi
    Farhat, Zeinab
    Ferrante, Marc
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S637 - S638
  • [22] Clinical, Endoscopic, and Radiological Effectiveness of Ustekinumab in Bio-naive Versus Bio-experienced Patients With Crohn's Disease: Real-world Experience From a Large Canadian Center
    Sedano, Rocio
    Guizzetti, Leonardo
    McDonald, Cassandra
    Beaton, Melanie
    Chande, Nilesh
    Gregor, Jamie
    Sey, Michael
    Wilson, Aze
    Jairath, Vipul
    INFLAMMATORY BOWEL DISEASES, 2023, 29 (06) : 866 - 874
  • [23] Cost-Effectiveness Comparison of Ustekinumab, Infliximab, or Adalimumab for the Treatment of Moderate-Severe Crohn's Disease in Biologic-Naive Patients
    Aliyev, Elmar R.
    Hay, Joel W.
    Hwang, Caroline
    PHARMACOTHERAPY, 2019, 39 (02): : 118 - 128
  • [24] Efficacy of Adalimumab in Korean Patients with Crohn's Disease
    Sohn, Il Woong
    Kim, Sung Tae
    Kim, Bun
    Lee, Hyun Jung
    Park, Soo Jung
    Hong, Sung Pil
    Kim, Tae Il
    Kim, Won Ho
    Cheon, Jae Hee
    GUT AND LIVER, 2016, 10 (02) : 255 - 261
  • [25] Real-World Long-Term Persistence and Surgical Procedure-Free Period Among Bio-naive Patients with Crohn's Disease and Fistula Initiated on Ustekinumab
    Zhdanava, Maryia
    Kachroo, Sumesh
    Boonmak, Porpong
    Burbage, Sabree
    Shah, Aditi
    Lefebvre, Patrick
    Kerner, Caroline
    Pilon, Dominic
    ADVANCES IN THERAPY, 2024, 41 (10) : 3922 - 3933
  • [26] THE ROLE OF INTESTINAL ULTRASOUND IN EVALUATING THE CLINICAL EFFICACY OF USTEKINUMAB TREATMENT IN PATIENTS WITH CROHN'S DISEASE
    Li, Manying
    Wu, Xiaomin
    Chen, Minhu
    Xie, Xiao-Yan
    Mao, Ren
    Chen, Yujun
    GASTROENTEROLOGY, 2024, 166 (05) : S1196 - S1197
  • [27] Real-World Clinical Effectiveness and Safety of Vedolizumab and Ustekinumab in Bio-Naive Patients With Non-Complicated Crohn's Disease: Results From the EVOLVE Expansion Study
    Ferrante, Marc
    Christensen, Britt
    Bressler, Brian
    Brett, Neil R.
    Gianchetti, Lauren
    Kamble, Pravin
    Adsul, Shashi
    Farhat, Zeinab
    Scharl, Michael
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S855 - S856
  • [28] Real-World Efficacy And Safety Of Ustekinumab And Adalimumab In Patients With Crohn's Disease: Propensity Matched Analysis
    Shin, Y.
    Hong, S. N.
    Kim, E. R.
    Chang, D. K.
    Kim, Y. H.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 842 - 842
  • [29] Persistence and other treatment patterns among bio-experienced patients with Crohn's disease initiated on ustekinumab or adalimumab
    Zhdanava, Maryia
    Zhao, Ruizhi
    Manceur, Ameur M.
    Ding, Zhijie
    Kachroo, Sumesh
    Holiday, Christopher
    Lefebvre, Patrick
    Pilon, Dominic
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2023, 29 (08): : 907 - 916
  • [30] PERSISTENCE AND OTHER TREATMENT PATTERNS AMONG BIO-EXPERIENCED PATIENTS WITH CROHN'S DISEASE INITIATED ON USTEKINUMAB OR ADALIMUMAB
    Zhdanava, Maryia
    Zhao, Ruizhi
    Manceur, Ameur M.
    Ding, Zhijie
    Kachroo, Sumesh
    Peddle, Mark
    Lefebvre, Patrick
    Pilon, Dominic
    GASTROENTEROLOGY, 2022, 162 (07) : S417 - S418
12345